Partnership Awards
The MRA Partnership Awards fund collaborative, cross-sector research projects to advance the prevention, diagnosis, staging, and treatment of melanoma through translational science.
Funder: Melanoma Research Alliance
Due Dates (Anticipated): September 2026 (LOI for Team Science and Academic-Industry Partnership) | January 2027 (Full proposal, invited only)
Funding Amounts: Funding levels for Partnership Awards are not specified; MRA typically supports at least $11.5M in new funding annually across its programs.
Summary: Supports cross-sector collaborations to accelerate translational melanoma research in prevention, diagnosis, staging, and treatment.
Key Information: This is a forecasted opportunity; dates and details are projected and subject to change.
Description
The Melanoma Research Alliance (MRA) Partnership Awards are designed to foster collaborations between sectors such as industry and nonprofit organizations, aiming to accelerate translational research in melanoma. These awards support projects that leverage the strengths and resources of diverse partners to advance prevention, diagnosis, staging, and treatment of melanoma. The Partnership Awards are part of MRA’s broader portfolio of grant mechanisms focused on high-impact, innovative, and collaborative research.
